PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1980551-2	1990	The results showed: (1) Secretin markedly inhibited spontaneous as well as pentagastrin stimulated antral motility.	Pentagastrin	75-87	secretin	Rattus norvegicus	24-32	
7958688-8	1994	RESULTS: Both basal- and pentagastrin-stimulated acid secretion were significantly inhibited by secretin.	Pentagastrin	25-37	secretin	Rattus norvegicus	96-104	
8420279-2	1993	Intravenous infusion of secretin (0.05 CU/kg/h) and intraduodenal administration of the secretin-releasing agent, plaunotol (320 mg/h), resulted in significant inhibition of gastric acid secretion stimulated by intravenous infusion of pentagastrin (0.3 micrograms/kg/h), and this was accompanied by an increase in the prostaglandin E2 content of the gastric mucosa.	Pentagastrin	235-247	secretin	Rattus norvegicus	24-32	
8420279-2	1993	Intravenous infusion of secretin (0.05 CU/kg/h) and intraduodenal administration of the secretin-releasing agent, plaunotol (320 mg/h), resulted in significant inhibition of gastric acid secretion stimulated by intravenous infusion of pentagastrin (0.3 micrograms/kg/h), and this was accompanied by an increase in the prostaglandin E2 content of the gastric mucosa.	Pentagastrin	235-247	secretin	Rattus norvegicus	88-96	
9655680-14	1998	Secretin significantly inhibited pentagastrin-stimulated acid secretion by 63% (P < 0.01), which was abolished by both vagotomy and PV treatment of Cap in conscious rats.	Pentagastrin	33-45	secretin	Rattus norvegicus	0-8	
9655680-17	1998	These results indicate that the inhibition by secretin of pentagastrin-stimulated acid secretion is mediated by a Cap-sensitive vagal afferent pathway but not via a splanchnic afferent pathway in rats.	Pentagastrin	58-70	secretin	Rattus norvegicus	46-54	
8568688-5	1995	Secretin given intravenously at 5.6 pmol kg-1 h-1 inhibited profoundly the acid secretion stimulated by pentagastrin at 0.3 microgram kg-1 h-1.	Pentagastrin	104-116	secretin	Rattus norvegicus	0-8	
8568688-7	1995	When a rabbit antisomatostatin serum was given intravenously, it not only abolished the secretin-induced inhibition on the pentagastrin-stimulated acid secretion, but also augmented both basal and pentagastrin-stimulated acid secretion.	Pentagastrin	123-135	secretin	Rattus norvegicus	88-96	
8568688-7	1995	When a rabbit antisomatostatin serum was given intravenously, it not only abolished the secretin-induced inhibition on the pentagastrin-stimulated acid secretion, but also augmented both basal and pentagastrin-stimulated acid secretion.	Pentagastrin	197-209	secretin	Rattus norvegicus	88-96	
8568688-14	1995	It is concluded that the inhibitory action of secretin on pentagastrin-stimulated gastric acid secretion is mediated by both somatostatin and prostaglandins in conscious rats.	Pentagastrin	58-70	secretin	Rattus norvegicus	46-54	
8103008-1	1993	We investigated the effect of indomethacin on secretin- and somatostatin-induced inhibition of gastric acid secretion stimulated by intravenous infusion of pentagastrin (0.3 microgram/kg.h) in anesthetized rats.	Pentagastrin	156-168	secretin	Rattus norvegicus	46-54	
1735364-2	1992	Intraduodenal administration of oleic acid emulsion in a dose of 1 mmol/hr resulted in significant inhibition of gastric acid secretion stimulated by intravenous infusion of pentagastrin (0.3 micrograms/kg/hr), and this was accompanied by an increase in the plasma concentration of both secretin and CCK, from 1.2 +/- 0.08 pM and 20.6 +/- 1.2 pM to 4.3 +/- 0.18 pM and 31.6 +/- 0.9 pM, respectively (P less than 0.001).	Pentagastrin	174-186	secretin	Rattus norvegicus	287-295	
1735364-3	1992	Intravenous infusion of secretin (0.05 CU/kg/hr) inhibited pentagastrin-stimulated gastric acid secretion, but CCK-8 (0.03 micrograms/kg/hr) failed, although intravenous infusion of secretin and CCK in those doses produced plasma levels comparable to the levels achieved in response to oleic acid administration.	Pentagastrin	59-71	secretin	Rattus norvegicus	24-32	
1450433-6	1992	Pentagastrin significantly increased ODC of the cecum, and secretin completely inhibited the effect of pentagastrin.	Pentagastrin	103-115	secretin	Rattus norvegicus	59-67	
54057-0	1975	The effect of secretin on pentagastrin-stimulated secretion of gastric pepsin and acid in rats.	Pentagastrin	26-38	secretin	Rattus norvegicus	14-22	
720345-7	1978	The C-terminal octapeptide of pancreozymin, desulfated caerulein and pentagastrin inhibited binding of [3H]caerulein whereas vasoactive intestinal polypeptide, secretin, bombesin or carbamoylcholine were wothout effect.	Pentagastrin	69-81	secretin	Rattus norvegicus	160-168	
23175-5	1978	Preincubation of the homogenate with 10(-8) M cholecystokinin or secretin inhibited gastrin binding to a greater extent than an equimolar concentration of pentagastrin.	Pentagastrin	155-167	secretin	Rattus norvegicus	65-73	
3792779-9	1987	Secretin had additive effects on pentagastrin-induced pancreatic growth.	Pentagastrin	33-45	secretin	Rattus norvegicus	0-8	
3792779-11	1987	Secretin has additive rather than inhibitory effects on pentagastrin-induced pancreatic growth.	Pentagastrin	56-68	secretin	Rattus norvegicus	0-8	
5770095-0	1969	Effect of secretin and cholecystokinin on the response of the gastric fistula rat to pentagastrin.	Pentagastrin	85-97	secretin	Rattus norvegicus	10-18